PSVKX | SSGSX | PSVKX / SSGSX | |
Total Expense Ratio | 0.89 | 1.26 | 71% |
Annual Report Gross Expense Ratio | 34.41 | 1.26 | 2,731% |
Fund Existence | 8 years | 27 years | - |
Gain YTD | 9.268 | 1.378 | 672% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 377M | 5.52B | 7% |
Annual Yield % from dividends | 1.29 | 0.48 | 270% |
Returns for 1 year | -2.12 | -4.40 | 48% |
Returns for 3 years | 6.80 | 7.68 | 88% |
Returns for 5 years | 57.08 | 22.15 | 258% |
Returns for 10 years | N/A | 20.72 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RIBEX | 67.25 | 0.24 | +0.36% |
American Funds Invmt Co of Amer R2E | |||
KLCIX | 21.68 | N/A | N/A |
Federated Hermes Kaufmann Large Cap IS | |||
JFNCX | 61.87 | N/A | N/A |
Janus Henderson Global Life Sciences C | |||
SLLAX | 13.84 | N/A | N/A |
SEI Small Cap F (SIMT) | |||
JEVCX | 11.08 | N/A | N/A |
JHancock Disciplined Value Em Mkts Eq C |